Regulus Therapeutics
RGLS
#7428
Rank
S$0.72 B
Marketcap
S$10.45
Share price
0.00%
Change (1 day)
434.86%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: S$0.72 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of S$0.72 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.72 B429.02%
2024S$0.13 B301.07%
2023S$34.18 M10.53%
2022S$30.92 M-50.24%
2021S$62.16 M-45.19%
2020S$0.11 B349.71%
2019S$25.21 M124.96%
2018S$11.21 M-92.25%
2017S$0.14 B-16.1%
2016S$0.17 B-73.47%
2015S$0.64 B-37.37%
2014S$1.03 B165.13%
2013S$0.39 B41.73%
2012S$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$133.38 B 18,341.28%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$39.18 B 5,317.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$169.57 B 23,344.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$321.49 B 44,347.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$133.74 B 18,391.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
S$39.25 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.81 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$37.17 B 5,039.20%๐Ÿ‡บ๐Ÿ‡ธ USA